Skip to content

Antidepressants to Avoid: What Antidepressants Should Not Be Taken With Buspirone?

2 min read

According to the FDA, combining buspirone with monoamine oxidase inhibitors (MAOIs) is contraindicated and can lead to a dangerous drug interaction. Understanding what antidepressants should not be taken with buspirone is crucial for preventing dangerous side effects, such as serotonin syndrome, and ensuring medication safety. This guide outlines the most significant risks and necessary precautions.

Quick Summary

Buspirone, an anxiolytic, should not be combined with MAOIs due to a high risk of serotonin syndrome and hypertensive crisis. Other serotonergic antidepressants, including SSRIs, SNRIs, and TCAs, can also increase the risk of serotonin syndrome and require careful medical supervision.

Key Points

  • MAOIs are strictly contraindicated with buspirone: Combining Monoamine Oxidase Inhibitors (MAOIs) with buspirone can lead to dangerous serotonin syndrome and hypertensive crisis.

  • SSRIs, SNRIs, and TCAs increase serotonin syndrome risk: While sometimes used together, combining buspirone with Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), or Tricyclic Antidepressants (TCAs) requires close monitoring due to increased risk of serotonin syndrome.

  • Watch for serotonin syndrome symptoms: Know the signs of serotonin syndrome, such as agitation, confusion, rapid heart rate, and muscle stiffness, and seek immediate medical help if they occur.

  • Nefazodone significantly increases buspirone levels: The antidepressant nefazodone can inhibit the metabolism of buspirone, increasing its concentration in the body and heightening the risk of side effects.

  • Communication with a doctor is essential: Always inform your healthcare provider about all medications and supplements you are taking to manage drug interactions effectively.

  • Maintain a 14-day washout period for MAOIs: If you or your doctor are transitioning between buspirone and an MAOI, a minimum 14-day waiting period is mandatory.

In This Article

Buspirone, sold under brand names like BuSpar, is an anti-anxiety medication used primarily for generalized anxiety disorder (GAD). It affects serotonin and dopamine receptors in the brain. Combining buspirone with certain antidepressants can be risky, with the most serious interactions occurring with Monoamine Oxidase Inhibitors (MAOIs).

The Critical Danger of Monoamine Oxidase Inhibitors (MAOIs)

MAOIs are an older class of antidepressants that pose a significant risk when combined with buspirone. This combination is strictly avoided. Risks include Serotonin Syndrome, a potentially fatal condition due to excessive serotonin activity, and Hypertensive Crisis, a dangerous rise in blood pressure.

A 14-day break is needed when switching between buspirone and an MAOI. Examples of MAOIs include phenelzine (Nardil), tranylcypromine (Parnate), isocarboxazid (Marplan), selegiline (Emsam), and certain reversible MAOIs like linezolid and intravenous methylene blue.

Serotonergic Antidepressants and the Risk of Serotonin Syndrome

Combining buspirone with other antidepressants that affect serotonin requires careful medical oversight. While sometimes used together to enhance effects, this increases the risk of serotonin syndrome. For more information, see {Link: Dr.Oracle https://www.droracle.ai/articles/43812/can-you-use-an-ssri-and-buspar-for-anxiety-management}.

A Comparison of Antidepressant Interaction Risks with Buspirone

Antidepressant Class Interaction Risk Mechanism Recommended Action
Monoamine Oxidase Inhibitors (MAOIs) Severe Significant serotonin increase and inhibition of breakdown leads to dangerously high serotonin levels and increased blood pressure. Strictly contraindicated. A 14-day washout period is required.
SSRIs & SNRIs High Increases serotonin availability in the brain, creating an additive effect with buspirone's serotonergic action. Requires careful medical supervision and monitoring for serotonin syndrome, though combinations are sometimes used.
Tricyclic Antidepressants (TCAs) High Increases both serotonin and norepinephrine, raising the risk of serotonin syndrome. Requires caution and close monitoring for serotonin syndrome.
Nefazodone Moderate Inhibits the enzyme that metabolizes buspirone, increasing its concentration and side effect risk. May require a significant dose reduction of buspirone.

Medication Safety Recommendations

Prioritize safety by: Sharing all medications and supplements with your doctor and pharmacist; avoiding changes to your medication dosage without medical advice; recognizing serotonin syndrome symptoms (agitation, rapid heartbeat, muscle stiffness) and seeking immediate help if they occur; and being aware that grapefruit and grapefruit juice can increase buspirone levels.

Conclusion

While generally safer than benzodiazepines, buspirone has significant drug interactions, most notably with MAOIs, which is strictly contraindicated due to the risk of serotonin syndrome and hypertensive crisis. More information can be found on the {Link: MedlinePlus https://medlineplus.gov/druginfo/meds/a688005.html} buspirone page.

Frequently Asked Questions

Combining buspirone with Selective Serotonin Reuptake Inhibitors (SSRIs) like Zoloft (sertraline) or Lexapro (escitalopram) is possible, but it significantly increases the risk of serotonin syndrome. This should only be done under the direct supervision of a healthcare provider who can carefully monitor for any adverse effects.

Buspirone should never be taken with an MAOI (Monoamine Oxidase Inhibitor) because both medications increase serotonin levels. The combination can cause a dangerous overload of serotonin, leading to serotonin syndrome or a hypertensive crisis (a sudden, severe spike in blood pressure).

If you accidentally combine buspirone with a contraindicated antidepressant, especially an MAOI, you should seek immediate medical attention. You should monitor for symptoms of serotonin syndrome, such as agitation, hallucinations, rapid heartbeat, or confusion.

A minimum 14-day washout period is required when switching between an MAOI and buspirone. This waiting period allows the body to clear the MAOI from the system and reduces the risk of dangerous interactions.

Yes, buspirone interacts with other medications and substances. These include certain antibiotics (like erythromycin and linezolid), some antifungals, calcium channel blockers (diltiazem, verapamil), and even grapefruit juice, which can increase buspirone levels.

Yes, buspirone is sometimes used off-label to augment other antidepressants like SSRIs and SNRIs, especially when initial treatment is not fully effective. However, this strategy carries an increased risk of serotonin syndrome and requires careful medical supervision and monitoring.

Symptoms of serotonin syndrome can include agitation, restlessness, confusion, hallucinations, a rapid heart rate, high blood pressure, muscle twitching or stiffness, tremors, flushing, sweating, seizures, and severe nausea or diarrhea.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.